Gee aren't you just a basket of optimism. Let's all get set for a tribal lifestyle of tent cities, wagons, epidemics and vigilantes (just like in the Walking Dead, ay?) ~ I can hardly wait !!! ~ Cheers.
"fake cities with no one living in them..." ~ you've got China mixed up with that comedy flick about North Korea.
BTW ndi, the P&L will give you a better picture of what is really happening than a static balance sheet, but neither of them is much good without cash flow. You need to get a handle liquidity to assess a company's health properly.
MZOR is breaking even. But you're right - there's lots of industry resistance to surgical robotics. You got to keep in mind, last thing a health care worker really wants is to have 4 guys like him replaced by a machine that costs a million bucks, and the one guy that doesn't get replaced, well he has to go back to school. So, what you get is a lot of noise about how "the capex is too high". Even if the machine amortizes itself, in many cases, over just a few dozen procedures, it's not going to be popular with a lot of health care workers, and they are who regulate the industry and make administrative decisions.
To answer the question... NO, none of the fundamentals have changed since the company traded sub $2 just a few weeks ago.
Yeah ~ it's a shelf filing - that's standard wording. But the thing is, this stock rallied from $2+ on a takeover rumor; now the float is in constant risk of dilution, and any takeover seems unlikely. Permanent dilution risk means the stock will languish when it hits bottom (wherever that is) and nothing but a powerful new catalyst will move it again. New investors will remain wary of any forthcoming rumor. Least ways, that's been my experience with penny biotechs after a pump & dump episode.
Other thing: this rally started a few weeks ago with takeover chatter. Clearly that's not happening anytime soon.
low volume? 330K shares - 1/3 of av daily volume - dumped in less than an hour.
So... TRXC announces $46M shelf filing (back to $2 wash & repeat). The NEOS letter wasn't very encouraging (to me) either. Basically what it said was: "We're not going to dilute right away ~ saving that card for later."
Well, it's a 13% MC dilution - right off the bat - and then nobody knows at what price the new shares will sell... So, yes lots of people will dump it tomorrow, and it will probably languish for some time after that. Dilution is the quickest way to kill a good rally. And it did come as a surprise, given $53M in cash & eq declared on the books. Glad I got out b4 the shytie news hit ~ no point in leaving 38% (or more) on the table.
Cheap oil is good for airlines, but Zika travel advisory puts half the Americas off limits.
You might get the feeling he doesn't like you, but that's just how he warms up to new friends.
Yeah, but you were buying into an RBC report and (well) RBC is a Canadian analyst... i can imagine CRM retracing to a $40 handle just as easily as $60, and then you can hold your breath thru earnings. It's hard to go long anything these days, while the SnP flirts with 1800, but TRXC seems like a good bet ~ it's been defying the market trend for a couple of weeks already ~ Robotic system already approved in EU and likely to be approved in US ~ MC of $360M (compare to ISRG $19B). It overshot today, so you might see a gap back to $4 by EOD.
Like i said ~ falling knife. You have to wait for the plunger to hit the bottom of the toilet bowl, stop and quiver for a bit... that's when it's safe to buy.
Walmart, like any other bricknmortar, must transition to predominately online sales -- the brick component remains competitively important (so that customers can exercise RMA without have to mail the goods back) but they certainly don't need as many shops as they used to -- more than half the USA shut-downs were within 10 m of another Walmart... so i guess, in future, we're going to have to get used to driving 10 m in order to return the stuff we bought online.